NCT07440979Active, not recruiting
Personalized Nutrition Coaching for a Weight Loss Program Among Overweight and Obese Nurses
Effects of Personalized Nutrition Coaching on Body Composition, Dietary Intake, Physical Activity Among Overweight and Obesity Nurses at Indonesian Hospital: A Randomized Control Trial
Source: ClinicalTrials.gov · Last updated 6 Mar 2026
Brief summary (registry, in English)
Obesity among healthcare workers has become an increasing public health concern, with potential consequences for work productivity, quality of care, and long-term health outcomes. Despite their role in promoting health, healthcare workers often face demanding schedules, high stress levels, and limited access to structured health promotion programs, placing them at elevated risk for overweight and obesity. In the absence of targeted workplace interventions, these conditions may persist and worsen over time, highlighting the need for effective, sustainable, and context-specific strategies to support healthier lifestyles among healthcare workers. This study aims to assess the effectiveness of personalized nutrition coaching as part of a weight loss program for Nurses in Indonesian Hospital. Participants who receive the intervention are expected to demonstrate improvements in nutritional status, including weight-related outcomes, reduction in body fat percentage, reduction in waist circumference. The intervention is also anticipated to promote healthier dietary intake, characterized by more balanced eating patterns, and higher levels of physical activity. Delivered through individualized online guidance, this program is intended to encourage sustainable lifestyle changes and improve overall health. The study will involve an 8-week intervention conducted among overweight and obese healthcare workers at Dr. Hasan Sadikin General Hospital, Bandung.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- First submitted
- 18 Feb 2026
- Start date
- 19 Jan 2026
- Primary completion date
- Mar 2026
- Lead sponsor
- Universitas Padjadjaran
- Diseases
- Obesity
- NCT number
- NCT07440979
What you commit to
- Study type: Interventional
- Planned participants: 44
- From 19 Jan 2026 to the primary completion date, Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking medications that may affect the study outcomes
Other illness
- Having special conditions such as food allergies, sensitivities, or intolerances, or following a specific dietary pattern (e.g., vegan diet or carbohydrate-restricted diet)
- Having a recent diagnosis or condition that may interfere with study outcomes (body weight, body fat percentage, waist circumference), such as edema or smoking cessation within the past 3 months
- Having diseases requiring dietary restriction or specialized Medical Nutrition Therapy (MNT), such as diabetes mellitus, kidney disease, or stroke
Other
- Being pregnant and/or breastfeeding.
- Currently participating in a calorie-restricted diet program
Who the study is looking for
- A Shift Nurse in Dr. Hasan Sadikin General Hospital Bandung
- Male and Female, Aged 18-35 years (Young Adult)
- Overweight (body mass index 23.0-24.99 kg/m²) or obese (body mass index ≥25.0 kg/m²)
- Willing to participate in the study and provide written informed consent
- Ownership of a smartphone and access to the internet
Age in the registry: 18 years to 35 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dr. Hasan Sadikin General Hospital Bandung Coordinator of this site? Confirm its status | Bandung | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.